Biograph finds coronary inflammation in 43% of asymptomatic adults
Biograph completed its first U.S. study integrating Caristo Diagnostics’ CaRi-Heart AI technology into its coronary CT angiography program. The study applied AI-enabled analysis alongside high-resolution CCTA and cardiometabolic profiling to evaluate coronary perivascular inflammation in asymp
<p>Biograph completed its first U.S. study integrating Caristo Diagnostics’ CaRi-Heart AI technology into its coronary CT angiography program. The study applied AI-enabled analysis alongside high-resolution CCTA and cardiometabolic profiling to evaluate coronary perivascular inflammation in asymp</p>